Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca2+ influx through L-type channels in mouse islet β-cells

Endocrine Journal

Volumn 58, Issue 4, 2011, Pages 305-313

  Nakata, Masanori ^a   Manaka, Kazunori ^a   Yamamoto, Sawako ^a   Mori, Masatomo ^b   Yada, Toshihiko ^a,c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Ca2+ signaling; Insulin release; Islet cell; L type Ca channel; Nesfatin 1

Indexed keywords

CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; NESFATIN 1; NEUROPEPTIDE; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; INSULIN RELEASE; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; PHOSPHOLIPASES A2;

EID: 79955764199     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K11E-056     Document Type: Article

References (36)

1. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443: 709-712.
2. Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, Yoshida N, Dezaki K, Onaka T, Mori M, Yada T (2008) Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149:1295-1301.
3. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ (2007) Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148: 5088-5094.
4. Yosten GLC, Samson WK (2009) Nesfatin-1 exerts cardiovascular effects in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 297: R330-R336.
5. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T (2009) Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metabolism 10: 355-365.
6. Gina L. C. Yosten and Willis K. Samson (2010) The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 298: R1642-R1647.
7. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Monnikes H, Lambrecht NW, Tache Y (2009) Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropinreleasing factor2 receptor. Endocrinology 150: 4911-4919.
8. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, Lambrecht NW (2009) Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150: 232-238.
9. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M (2009) Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150: 662-671.
10. Gonzalez R, Tiwari A, Unniappan S (2009) Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 381: 643-648.
11. Foo KS, Brauner H, Ostenson CG, Broberger C (2010) Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 204: 255-263.
12. Nakata M, Yada T (2007) PACAP in the glucose and energy homeostasis: physiological role and therapeutic potential. Curr Pharm Des 13: 1105-1112.
13. Yada T, Dezaki K, Sone H, Koizumi M, Damdindorj B, Nakata M, Kakei M (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4: 18-23.
14. Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. (2002) Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440:269-279.
15. Gilon P, Shepherd RM, Henquin JC (1993) Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J Biol Chem 268: 22265-22268.
16. Nakata M, Yada T (2008) Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors. Regul Pept 145: 49-53.
17. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F. (1996) Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45: 257-261.
18. Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G. (2002) Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Endocrinology 143: 1253-1259.
19. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M (1994) Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells. J Biol Chem 269: 1290-1293.
20. Yada T, Itoh K, Nakata M (1993) Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic β-cells by enhancing Ca2+ channel activity. Endocrinology 133: 1685-1692.
21. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987) Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84: 3434-3438.
22. Seino S, Shibasaki T (2005) PKA-dependent and PKAindependent pathways for cAMP-regulated exocytosis. Physiol Rev 85: 1303-1342.
23. Jones PM, Persaud SJ (1993) Arachidonic acid as a second messenger in glucose-induced insulin secretion from pancreatic β cells. J Endocrinol 137: 7-14.
24. Kato M, Ma HT, Tatemoto K (1996) GLP-1 depolarizes the rat pancreatic β cell in a Na+-dependent manner. Regul Pept 62: 23-27.
25. Hiriart M, Matteson DR (1988) Na channels and two types of Ca channels in rat pancreatic β cells identified with the reverse hemolytic plaque assay. J Gen Physiol 91: 617-639.
26. Arkhammar P, Juntti-Berggren L, Larsson O, Welsh M, Nånberg E, Sjöholm A, Köhler M, Berggren PO (1994) Protein kinase C modulates the insulin secretory process by maintaining a proper function of the β-cell voltage-activated Ca2+ channels. J Biol Chem 269: 2743-2749.
27. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS (2010) Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151: 3169-3180.
28. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M. (2010) Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 73: 484-490.
29. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404: 661-671.
30. Figlewicz DP, Benoit SC (2009) Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol 296: R9-19.
31. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M (2004) Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10: 168-174.
32. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY (2010) Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 159: 72-77.
33. Abdel-Halim SM, Guenifi A, Luthman H, Grill V, Efendic S, Ostenson CG (1994) Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes 43: 281-288.
34. Maekawa F, Fujiwara K, Kohno D, Kuramochi M, Kurita H, Yada T (2006) Young adult-specific hyperphagia in diabetic Goto-Kakizaki rats is associated with leptin resistance and elevation of neuropeptide Y mRNA in the arcuate nucleus. J Neuroendocrinology 18: 748-756.
35. Iguchi H, Ikeda Y, Okamura M, Tanaka T, Urashima Y, Ohguchi H, Takayasu S, Kojima N, Iwasaki S, Ohashi R, Jiang S, Hasegawa G, Ioka RX, Magoori K, Sumi K, Maejima T, Uchida A, Naito M, Osborne TF, Yanagisawa M, Yamamoto TT, Kodama T, Sakai J. (2005) SOX6 attenuates glucose-stimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice. J Biol Chem 280: 37669-37680.
36. Su Y, Zhang J, Tang Y, Bi F, Liu JN (2010) The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 391: 1039-1042.